Apotheek Omnia
ActiveApotheek Omnia has been active since 1952 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €860k and a net result of €56k. Equity is growing by ~13.9% per year across the filed fiscal years. Its solvency ranks better than 79% of 10252 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
81
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-3
Solvency92▲+13
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €65k at 30 days acceptable
Liquidity ample (current ratio 1.75 against 2.04 in 2024; short-term debt: 21.5% and cash: 9% of total assets), and 32.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
67.4%
Return on assets
4.4%
Age of the figures
13 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-08-2025 was due by 31-03-2026 and was filed on 03-02-2026, 56 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
56 d early
2024
103 d early
2023
103 d early
2022
105 d early
2021
114 d early
2020
99 d early
2019
137 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-08-2026 and is due by 31-03-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-08-2026 close17-09-2026 today31-03-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€860k▲ 7.0%
2024 · €804k
2019: €399k
2020: €449k
2021: €514k
2022: €663k
2023: €708k
2024: €804k
2019 → 2025
Total assets
€1.28M▼ 14.9%
2024 · €1.50M
2019: €951k
2020: €1.13M
2021: €1.18M
2022: €1.41M
2023: €1.46M
2024: €1.50M
2019 → 2025
Net result
€56k▼ 41.5%
2024 · €96k
2019: €30k
2020: €50k
2021: €65k
2022: €149k
2023: €45k
2024: €96k
2019 → 2025
Working capital
€208k▼ 19.1%
2024 · €256k
2019: €-21k
2020: €47k
2021: €264k
2022: €256k
2023: €148k
2024: €256k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€514k-€663k▲ 29.0%€708k▲ 6.8%€804k▲ 13.5%€860k▲ 7.0%
Operating result€98k-€202k▲ 107%€64k▼ 68.2%€134k▲ 108%€75k▼ 43.8%
Net result€65k-€149k▲ 130%€45k▼ 69.5%€96k▲ 111%€56k▼ 41.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 44% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.28M
Fixed assets
€794k▼ 20.4%
Current assets
€483k▼ 4.1%
Equity and liabilities €1.28M
Equity
€860k▲ 7.0%
Debt
€416k▼ 40.2%
The debt ratio falls from 46.4% to 32.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€98k▼
2024 · €161k
Cash flow
€79k▼
2024 · €123k
Solvency
67.4%▲
2024 · 53.6%
Current ratio
1.75▼
2024 · 2.04
Quick ratio
0.92▼
2024 · 1.13
Debt / equity
0.48▼
2024 · 0.87
ROE
6.5%▼
2024 · 11.9%
ROA
4.4%▼
2024 · 6.4%
Interest coverage
49.18▼
2024 · 75.43
Debt
€416k▼
2024 · €697k
Debt ≤ 1 year
€275k▲
2024 · €247k
Debt > 1 year
€140k▼
2024 · €449k
Income taxes
€21k▼
2024 · €37k
Staff costs
€162k▼
2024 · €176k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.50M€1.28M▼
Fixed assets21/28€997k€794k▼
Tangible fixed assets22/27€394k€371k▼
Land and buildings22€394k€371k▼
Financial fixed assets28€603k€422k▼
Current assets29/58€503k€483k▼
Stocks and contracts in progress3€223k€231k▲
Stocks30/36€223k€231k▲
Amounts receivable within one year40/41€84k€112k▲
Trade receivables40€54k€107k▲
Other amounts receivable41€30k€4k▼
Current investments50/53€101k€20k▼
Cash at bank and in hand54/58€85k€115k▲
Deferred charges and accrued income490/1€9k€5k▼
Equity and liabilities
Total equity and liabilities10/49€1.50M€1.28M▼
Equity10/15€804k€860k▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€742k€798k▲
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€736k€792k▲
Profit (loss) carried forward14€138€196▲
Amounts payable17/49€697k€416k▼
Amounts payable after more than one year17€449k€140k▼
Financial debts170/4€24k€14k▼
Other amounts payable178/9€425k€126k▼
Amounts payable within one year42/48€247k€275k▲
Current portion of amounts payable after more than one year42€10k€10k=
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€136k€231k▲
Suppliers440/4€136k€231k▲
Advances received on contracts in progress46-€522
Taxes, remuneration and social security45€64k€33k▼
Taxes450/3€48k€12k▼
Remuneration and social security454/9€16k€22k▲
Other amounts payable47/48€37k€368▼
Accrued charges and deferred income492/3€900€821▼
Income statement
Code20242025
Remuneration, social security and pensions62€176k€162k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€27k€23k▼
Other operating charges640/8€10k€10k▲
Gross operating margin9900€347k€270k▼
Operating profit (loss)9901€134k€75k▼
Financial income75/76B€1k€4k▲
Recurring financial income75€1k€4k▲
Financial charges65/66B€2k€2k▼
Recurring financial charges65€2k€2k▼
Profit (loss) for the period before taxes9903€133k€77k▼
Income taxes67/77€37k€21k▼
Profit (loss) for the period9904€96k€56k▼
Profit (loss) for the period to be appropriated9905€96k€56k▼
Appropriation of the result
Profit (loss) to be appropriated9906€96k€56k▼
Profit (loss) brought forward from the previous period14P€302€138▼
Transfer to equity691/2€96k€56k▼
To other reserves6921€96k€56k▼
Social balance
Average headcount (FTE)90873.43.0▼
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-02
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2024
18-12
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2023
19-12
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
16-12
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
31-08
Financial
Highest result since 2019net €149k ▲130%
Operating result €202k, net result €149k, both a record.
2021
07-12
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
31-08
Financial
Liquidity doublescurrent ratio 2.36
Current ratio from 1.08 to 2.36; short-term debt falls from €613k to €195k.
31-08
Financial
Equity above €500kEq €514k ▲14.4%
3 profitable years in a row build equity to €514k.
2020
22-12
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2019
15-11
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
11-01
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
22-12
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
23-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2025
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
01-01-2025
Marceau Decru: Resigned as Director
15-11-2019
Geert DECRU: Resigned as Director
15-11-2019
Geert DECRU: Resigned as Managing director
15-11-2019
Pascale HOUVENAGHEL: Resigned as Director
01-03-2015
Hendrik DECUPERE: Resigned as Director
01-09-2014
Luc Lefebvre: Resigned as Director
01-09-2014
SPEECKE Greta: Resigned as Director
Location & real-estate footprint
Registered office, Koksijde · 1 establishment unit since 1952
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Koninklijke Baan(Kok) 1548670 KoksijdeGround area
179 m²
Building footprint
196 m²
Volume, LiDAR
2,320 m³
Parcel 38014E0330/00_000, Flanders · tallest building 20.9 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK OMNIA
since 19522.004.154.216
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38014E0330/00_000 | Flanders | 179 m² | 1 · 196 m² | 20.9 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Apotheek C. Wouters
BE 0832.746.285
Lommel · Eq €859k
APOTHEEK DE BRABANDERE OUDENAARDE
BE 0829.433.538
Oudenaarde · Eq €859k
PHARMACIE VAN HAREN
BE 0477.842.289
Sprimont · Eq €861k
LUDAPHAR
BE 0419.832.529
Beauvechain · Eq €859k
DE POURCQ FARMA
BE 0896.643.551
Mechelen · Eq €861k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,128 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded21-01-1952
Fiscal year end31-08
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.